M
ale
urinary
incontinence
: A
rtificial
sphincter
R
ev
A
ssoc
M
ed
B
ras
2017; 63(8):664-680
669
5.7% (ARR = 5.7%, 95CI 0.048-0.066; NNT = 18, 95CI 15-21)
and risk of revision of 2% (ARR = 2%, 95CI 0.12-0.028; NNT
= 50, 95CI 36-83). There was no difference between the
groups regarding the risk of atrophy.
8
(C)
Another historical cohort
46
(B)
included data from
84 patients with stress urinary incontinence after prostate
surgery, monitored for an average of 39.7 months and
submitted to AUS implantation (5% primary). In a sub-
group analysis, perineal access (N = 24) compared to scro-
tal access (N = 60) reduced the risk of erosion by 20% (ARR
= 20%, 95CI 0.099-0.301; NNT = 5, 95CI 3-10). There were
no significant differences between the groups in the num-
ber of irradiated and/or anticoagulated patients, nor in
the number of patients submitted to double-cuff place-
ment (p=0.44, 0.22 and 0.76, respectively).
46
(B)
Also, a
recent historical cohort
47
(B)
compared perineal (N = 152)
and penoscrotal access (N = 99) in the single cuff implan-
tation. The comparison of the two groups showed that
the perineal route reduced the risk of explantation by 10.6%,
in the 6-month follow-up (RRA = 10.6%, 95CI 0.017-0.195;
NNT = 9, 95CI 5-61).
47
(B)
A historical cohort study compared the scrotal to the
perineal approach in a total of 126 artificial urinary sphinc-
ter cuffs (120 procedures, including double cuff placement
in six), implanted in 94 patients, 63 of which were placed via
the penoscrotal approach and 63 via the perineal approach.
In the subgroup analysis with patients undergoing a
primary or revision procedure with a single cuff, the num-
ber of patients “completely dry” (without using pads) was
higher in the “perineal” group (ARA = 28%, 95CI -0.48 to
-0.07; NNH = 4, 95CI 2-14). Furthermore, perineal access
also showed a greater number of “completely dry” patients
(ARA = 28.7, 95CI -0.53 to -0.03; NNH = 3, 95CI 2-27).
The number of patients in the trans-scrotal group and in
the perineal group who required double cuff implantation
due to incontinence was 18 and 3%, respectively (p=0.6,
without statistical significance).
48
(B)
A before-and-after study (N = 30)
8
(C)
reported excel-
lent results with an improved technique using a single
scrotal incision, allowing a more proximal placement of
the cuff and the attainment of a continence rate similar
to those obtained with the perineal approach found in
the literature.
8
(C)
Another before-and-after study
31
(C)
evaluated 83
highrisk patients (69% prostatectomy only and 31% with
radiotherapy and/or cryotherapy) who underwent AUS
implantation with a single transverse scrotal incision. In an
average follow-up of 18.8 (14.6) months, the number of
pads per day decreased from a mean of 6.7 in the preopera-
tive period to 1.1 in the postoperative period. Overall, 83%
of the patients (79% of the irradiated ones and 85% of the
nonirradiated ones) used ≤ 1 pad/day after surgery.
49
(C)
Authors have evaluated the implantation of AUS and
inflatable penile prosthesis simultaneously through a
single trans-scrotal incision. They included 22 patients
with urinary incontinence and erectile dysfunction result-
ing from radical prostatectomy in 21 patients and radical
cystectomy in one. The average follow-up time was 17
(12-36) months. The total revision rate was 14%, due to
urethral erosion in two patients and migration of the
reservoir in one. All patients reported improvement in
urinary loss, requiring ≤ 1 pad/day. No patient suffered
prosthesis infection in the postoperative period.
50
(C)
A consensus of the International Continence Society
(ICS) recommends that the penoscrotal approach be reserved
for reoperation; patients with conditions that prevent place-
ment in the lithotomy position (morbid obesity, spine or
limb deformities, neuromotor conditions); and patients who
will undergo the AUS implantation and inflatable penile
prosthesis through a single penoscrotal incision.
31
(D)
Global evidence summary
The implantation of the AUS via the penoscrotal route can
increase the risk of erosion, infection and explantation.
(B)
The penoscrotal technique may not provide an ad-
vantage in relation to efficacy, and is associated with a
lower continence rate than the perineal approach.
(B)
The penoscrotal approach can be reserved for cases
of reoperation; patients with conditions that impede
placement in the lithotomy position (morbid obesity,
spine or limb deformities, neuromotor conditions); pa-
tients who will undergo AUS implantation and inflatable
penile prosthesis through a single penoscrotal incision;
and patients with a previously implanted sling.
(D)
The perineal approach should be the usual one.
(B)
4. T
ranscorporal
approach
for
cuff
placement
The aim of our evaluation is, based on primary studies,
to compare the transcorporal placement of the cuff with
the “standard” placement (directly around the urethra),
regarding efficacy and safety.
Clinical question
What is the best approach for cuff placement in artificial
urinary sphincter implant surgery? This question was
answered based on the PICO method, in which P stands
for patients with moderate to severe urinary incontinence;
I is the intervention with transcorporal cuff implantation;
C is the comparison with “standard” cuff implantation;